Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Scale Computing Targets 50% YoY Growth as Record Q1 2024 is Fueled by Channel Partners and Customers Seeking VMware Alternative Solutions
-
KnowBe4 Named the Number One Leader in the G2 Grid Spring 2024 Report in Two Categories
-
Northstar Receives C$1.34 Million from ERA in Grant Funding Following Approval of First Milestone
-
RICE KRISPIES TREATS® FANS REJOICE! OUR #1 MOST REQUESTED FLAVOR HAS ARRIVED: CHOCOLATEY PEANUT BUTTER
-
LoanCare® Receives Fitch Rating for Closed-End Second Lien Products
-
Yardi Launches Energy Relief for Federal Energy Rebate and Solar Programs
-
Leidos awarded $267 million Army C5ISR and COTS systems task order
-
PAYZLI ANNOUNCES THE SELECTION OF MICHAEL LACAPRIA TO ITS BOARD OF DIRECTORS
-
Spinogenix Announces U.S. FDA Approval of its Investigational New Drug Application for its Phase 2a Clinical Trial of SPG601 for Fragile X Syndrome
-
Safehold Announces New $2.0 Billion Unsecured Revolving Credit Facility
-
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
-
Satellogic Announces $30 Million Strategic Investment from Tether Investments Limited
-
UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
-
Caliber Updates Timing of Fourth Quarter and Full Year 2023 Earnings Release on April 15, 2024
-
NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression
-
Great Pacific Gold to Acquire Papua New Guinea Focused Tinga Valley Copper & Gold Corp.
-
Wound Care Plus, LLC Revolutionizes Wound Management with ARANZ Medical's Silhouette Solution
-
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
-
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
-
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
-
Alpha to Announce First Quarter 2024 Financial Results on May 6
-
Neurvati Neurosciences Announces Appointment of Deborah Dunsire, MD, as Member and Chair of Company Board of Directors
-
HSBC Achieves 15% Uplift in Monthly Card Spend Using FICO’s AI-Powered Optimization
-
Hammerspace Expands Support for Commodity Hardware in the Global Data Environment
-
Obsidian Therapeutics Appoints Jeffrey Trigilio as Chief Financial Officer
-
Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
-
Slate Grocery REIT Announces Distribution for the Month of April 2024
-
Allura Capital Announces Partnership to Form a Real Estate Investment Firm Focused on the Needs of the Individual Investor
-
Green Dot Appoints Renata Caine to Lead Banking as a Service
-
Cognito Therapeutics Announces Spectris™ Demonstrates Durable Effects on Activities of Daily Living in the OVERTURE II Study
-
Cloudiway at Google Cloud Next 2024: Introduces Game-Changing Solutions for Team Collaboration Migration
-
AMETEK Announces First Quarter 2024 Earnings Call and Webcasted Investor Conference Call Information
-
FICO Platform Produced a Significant Return on Investment for Businesses According to New Total Economic Impact Study
-
University of Phoenix Supports Fresh Start Women’s Foundation Annual Fundraising Gala
-
Mastercard and Leading Canadian Fintech VoPay Enter Strategic Partnership to Empower Canadians to Move Money Quickly and Securely with Mastercard Move
-
EQT Announces Non-Operated Asset Transaction with Equinor
-
Dignari Wins Strategic U.S. Customs and Border Protection Blanket Purchase Agreement
-
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
-
Syntec Optics (Nasdaq: OPTX) Announces Executive Changes to Support Growth Plan
-
Avenacy Announces Launch of Desmopressin Acetate for Injection in the U.S. Market
-
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII confer
-
Inspired Reports Fourth Quarter and Full Year 2023 Results
-
Arqit founders to buy shares
-
VERSES Provides Q1 2024 Corporate Update
-
Reunion Gold Infill Drilling Continues to Expand the Zone of High-Grade Gold Mineralization on Block 6 at its Oko West Project, Guyana
-
TX Holdings Inc. Borrows New Business Loan
-
General Motors Names HARMAN a 2023 Supplier of the Year
-
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
-
VCI Global Hits Key Growth Milestone by Completing Its Second Technology Acquisition; a Leading AI Gamification Platform Serving Global Brands
-
LANDSEA HOMES CLOSES ON 28 HOMESITES IN LONGMONT, COLORADO

